Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07773272
Recruiting
Cardiovascular-kidney-metabolic (CKM)-Guided Therapy for Patients After Acute Coronary Syndrome
Not applicable · Netherlands · 1 site
Registry update: 19 Aug 2026
NCT07788859
Recruiting
Reliability and Validity of Three DT-TUG Protocols in MS
Not applicable · 1 site
Registry update: 27 Aug 2026
NCT07461415
Recruiting
Coaching and Navigation by Community Health Workers (CHWs) Through Telehealth for High-risk Hypertension
Not applicable · Pakistan · 5 sites
Registry update: 17 Sept 2026
NCT07475403
Recruiting
Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer
Phase 2 · China · 3 sites
Registry update: 26 May 2026
NCT07104630
Recruiting
Pulmonary Rehabilitation in Advanced Lung Cancer Survivors
Phase 2 · United States · 1 site
Registry update: 22 Sept 2026
NCT07467993
Recruiting
Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
Phase 2 · Bulgaria, United States · 15 sites
Registry update: 29 Jul 2026
NCT05917210
Recruiting
Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda
Not applicable · Uganda · 1 site
Registry update: 20 Mar 2026
NCT07351045
Recruiting
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Phase 3 · Argentina, Australia, Belgium, Brazil, Canada, China, Czechia, Germany, Spain, France, United Kingdom, Hungary, India, Italy, Japan, South Korea, Mexico, Netherlands, Poland, Taiwan, United States · 209 sites
Registry update: 13 Oct 2026
NCT07482176
Recruiting
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Phase 3 · United States · 79 sites
Registry update: 24 Sept 2026
NCT06725173
Recruiting
Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.
Not applicable · United States · 1 site
Registry update: 18 Mar 2026
NCT07010497
Recruiting
A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Bevacizumab in Patients With Hepatocellular Carcinoma
Phase 2 · South Korea · 3 sites
Registry update: 15 Jul 2026
NCT07402226
Recruiting
Systemic Sclerosis DIet for GastrointESTinal Symptoms
Not applicable · United States · 1 site
Registry update: 1 Jul 2026
NCT07457580
Recruiting
Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)
Not applicable · Belgium, Germany, Spain, France, United Kingdom, Italy · 14 sites
Registry update: 26 Aug 2026
NCT07540949
Recruiting
Rutazyme Lemon Fermented Product Capsules for Metabolic Function in Adults With Obesity
Not applicable · Taiwan · 1 site
Registry update: 21 Apr 2026
NCT06907095
Recruiting
Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk Individuals
Not applicable · France · 1 site
Registry update: 30 Mar 2026
NCT07087912
Recruiting
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Phase 4 · Brazil · 2 sites
Registry update: 20 Jul 2026
NCT07444008
Recruiting
Randomized, Blinded, Placebo-Controlled Evaluation of BioAmicus Complete
Not applicable · Russia · 1 site
Registry update: 11 May 2026
NCT07291076
Recruiting
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
Phase 1/2 · Australia, Chile, China, Germany, Spain, France, United Kingdom, Italy, Japan, South Korea, Poland, Singapore, Taiwan, United States · 67 sites
Registry update: 23 Oct 2026
NCT07472881
Recruiting
Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women
Not applicable · Taiwan · 1 site
Registry update: 20 Mar 2026
NCT07003542
Recruiting
A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
Phase 2 · United States · 1 site
Registry update: 6 Aug 2026

Ordered by registry start date. Freshness and sponsorship never change the order.